Immune Design raises $80M follow-on

On Oct. 24, immunotherapy company Immune Design Corp. (NASDAQ:IMDZ) raised $80 million through the sale of 19.5 million shares at $4.10 in a follow-on underwritten by Leerink, Cowen and RBC Capital Markets. The price is a 21% discount to the company’s close of $5.20 on Oct. 23, when it proposed after market close to sell 16 million shares...